Terns Pharmaceuticals, Inc. develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
| Market Cap | 640.366 Million | Shares Outstanding | 56.67 Million | Avg 30-day Volume | 568.887 Thousand |
| P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -1.43 |
| Price to Revenue | 0.0 | Debt to Equity | 0.0 | EBITDA | -72.799 Million |
| Price to Book Value | 2.8718 | Operating Margin | 0.0 | Enterprise Value | 528.65 Million |
| Current Ratio | 24.747 | EPS Growth | 0.239 | Quick Ratio | 24.571 |
| 1 Yr BETA | 0.7648 | 52-week High/Low | 14.04 / 1.6 | Profit Margin | 0.0 |
| Operating Cash Flow Growth | -22.984 | Altman Z-Score | 35.569 | Free Cash Flow to Firm | -43.362 Million |
| Earnings Report | 2023-08-07 |
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
YOON SEOKHO BRYAN COO AND GENERAL COUNSEL |
|
7,659 | 2023-02-01 | 1 |
|
SUNDARAM SENTHIL VEL CHIEF EXECUTIVE OFFICER |
|
7,659 | 2023-02-01 | 1 |
|
VIGNOLA MARK J. CHIEF FINANCIAL OFFICER |
|
7,659 | 2023-02-01 | 1 |
|
QUIRK ERIN PRESIDENT, HEAD OF R&D |
|
0 | 2023-02-01 | 1 |
|
5,645,254 | 2022-12-23 | 2 | |
|
5,645,254 | 2022-12-23 | 3 | |
|
6,657,992 | 2022-12-23 | 3 | |
|
4,340,212 | 2022-12-23 | 4 | |
|
3,281,566 | 2022-11-23 | 1 | |
|
0 | 2022-07-26 | 2 | |
|
RUSSELL KERRY STRONG CHIEF MEDICAL OFFICER |
|
240,000 | 2022-07-01 | 1 |
|
32,000 | 2022-06-16 | 1 | |
|
32,000 | 2022-06-16 | 1 | |
|
32,000 | 2022-06-16 | 1 | |
|
32,000 | 2022-06-16 | 1 | |
|
No longer subject to file | 2021-02-09 | 0 | |
|
7,107,408 | 2021-02-09 | 2 | |
|
4,875,266 | 2021-02-09 | 0 | |
|
0 | 2021-02-04 | 0 |
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | ||||||||||||||||
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|---|---|---|---|
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 22:15:04 UTC | 3.3972 | 1.6728 | 600000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 21:45:04 UTC | 3.3972 | 1.6728 | 600000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 21:15:05 UTC | 3.3972 | 1.6728 | 600000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 20:45:03 UTC | 3.3972 | 1.6728 | 600000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 20:15:04 UTC | 3.3972 | 1.6728 | 600000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 19:45:03 UTC | 3.3972 | 1.6728 | 600000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 19:15:04 UTC | 3.3972 | 1.6728 | 500000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 18:45:03 UTC | 3.3972 | 1.6728 | 500000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 18:15:04 UTC | 3.3972 | 1.6728 | 600000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 17:45:04 UTC | 3.3972 | 1.6728 | 600000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 17:15:04 UTC | 3.3972 | 1.6728 | 500000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 16:45:04 UTC | 3.398 | 1.662 | 500000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 16:15:04 UTC | 3.398 | 1.662 | 500000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 15:45:03 UTC | 3.398 | 1.662 | 500000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 15:15:04 UTC | 3.398 | 1.662 | 600000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 14:45:04 UTC | 3.398 | 1.662 | 600000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 14:15:04 UTC | 3.398 | 1.662 | 500000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 13:45:04 UTC | 3.5418 | 1.5182 | 500000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 13:15:04 UTC | 3.5418 | 1.5182 | 600000 |
| TERNS PHARMACEUTICALS INC TERN | 2023-06-01 12:45:04 UTC | 3.5418 | 1.5182 | 600000 |
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|
